检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:Wenke Xu Yongxun Ge Yu Hou Yingju Liu Yingchun Hua Weiwei Han Zhiyan Qin Fengwu Liu
机构地区:[1]School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China [2]Collaborative Innovation Center of Henan New Drug Research and Safety Evaluation, Zhengzhou, Henan 450001, China [3]Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan 450007, China [4]Oepartment of Medicine, Kaifeng University, Kaifeng, Henan 475000, China
出 处:《Chinese Journal of Chemistry》2017年第9期1437-1444,共8页中国化学(英文版)
基 金:We gratefully acknowledge financial support from the National Natural Science Foundation of China (No. 21372207).
摘 要:A series of spiro-oxadiazoles were synthesized from 1,4:3,6-dianhydro-D-fructose and hydrazides via a stereoselective two-step reaction sequence. The structures of newly synthesized compounds were established by spectral analysis. The absolute configuration of compound 2a was further confirmed by single crystal X-ray analysis. All the synthesized compounds were screened for their in vitro antitumor activity, showing that these compounds have poor inhibitory activities against A549, MGC-803 tumor cells.A series of spiro-oxadiazoles were synthesized from 1,4:3,6-dianhydro-D-fructose and hydrazides via a stereoselective two-step reaction sequence. The structures of newly synthesized compounds were established by spectral analysis. The absolute configuration of compound 2a was further confirmed by single crystal X-ray analysis. All the synthesized compounds were screened for their in vitro antitumor activity, showing that these compounds have poor inhibitory activities against A549, MGC-803 tumor cells.
关 键 词:1 4:3 6-dianhydro-D-froctose spiro-oxadiazole single crystal X-ray analysis antitumor activity
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.217.13.162